期刊文献+

A型肉毒毒素对增生性瘢痕组织中TGF-β1和Ⅰ型胶原蛋白mRNA表达的影响 被引量:7

Study on BTXA on the expression of TGF-β1 and collagen Ⅰin hypertrophic scar
在线阅读 下载PDF
导出
摘要 目的:探讨A型肉毒毒素(botulinum toxin A,BTXA)对增生性瘢痕组织成纤维细胞中TGF-β1和Ⅰ型胶原蛋白表达的影响。方法:组织块法培养增生性瘢痕组织及正常皮肤组织的成纤维细胞,用不同浓度的BTXA作用于体外培养的人增生性瘢痕成纤维细胞,检测MTT值;将浓度为0.2U/ml、0.4U/ml、0.8U/ml BTXA作用于增生性瘢痕成纤维细胞48h,利用RT-PCR检测BTXA对TGF-β1和Ⅰ型胶原蛋白m RNA的表达量。结果:BTXA在体外能明显抑制增生性瘢痕成纤维细胞的增殖,随着药物浓度的增加及时间的延长,其抑制作用明显增强,能够减少TGF-β1和Ⅰ型胶原蛋白m RNA的表达,且随着药物浓度的增加,TGF-β1和Ⅰ型胶原蛋白m RNA的表达量呈下降趋势。结论:BTXA通过抑制瘢痕组织中成纤维细胞的增殖,减少TGF-β1和Ⅰ型胶原蛋白m RNA的表达,减少细胞外基质的异常沉积来影响增生性瘢痕的形成。 Objective To investigate the effect of botulinum toxin A (BTXA)on the expression of TGF-β1 and collagenⅠin hypertrophic scar fibroblast. Methods After treated with different concertrations of BTXA,the inhibition rate of hypertrophic scar fibroblasts were detected by MTT assay,0.2U/ml,0.4 U/ml and 0.8U/ml of BTXA was added in cultured hypertrophic scar fibroblast for 48h,the expression of TGF-β1 and collagenⅠin hypertrophic scar fibroblasts was respectively detected with RT-PCR. Results BTXA can significantly inhibit the proliferation of hypertrophic scar fibroblast,and the expression of TGF-β1and collagenⅠcould be inhibited significantly,the levels of the proliferation of hypertrophic scar fibroblast and the expression of TGF-β1 and collagenⅠdecreased along with the increase in BTXA concertration. Conclusion BTXA inhibits hypertrophic scar formation through inhibiting the proliferation of hypertrophic scar fibroblast and down-regulating the expression of TGF-β1 and collagenⅠ.
出处 《中国美容医学》 CAS 2015年第7期40-43,共4页 Chinese Journal of Aesthetic Medicine
关键词 A型肉毒毒素 增生性瘢痕 TGF-Β1 collagenⅠ botulinum toxin A hypertrophic scar
  • 相关文献

参考文献7

二级参考文献107

共引文献82

同被引文献65

  • 1李喆,李世荣,刘剑毅,戴霞,陈康,陶灵.结缔组织生长因子体外促进人增生性瘢痕成纤维细胞转分化的研究[J].第三军医大学学报,2006,28(8):775-777. 被引量:17
  • 2于波,陈敏亮,刘文阁,孙同柱,付小兵.A型肉毒毒素对增生性瘢痕成纤维细胞的影响[J].中国美容医学,2008,17(1):72-75. 被引量:22
  • 3Rosenstengel C , Matthes M, Baldauf J , Fleck S , Schroeder H.Hemifacial spasm : conservative and surgical treatment options.Dtsch Arztebl Int, 2012, 109 (41) : 667-673.
  • 4NasrMW, JabbourSF, SidaouiJA, Haber RN, Kechichian EG.Botulinum Toxin for the Treatment of Excessive Gingival Display :A Systematic Review. Aesthet Surg J, 2016 , 36 (1) : 82-88.
  • 5Carruthers J , Carruthers A. Botulinum toxin in facial rejuvenation:an update. Dermatol Clin, 2009, 27 (4 ) : 417-425.
  • 6Mazzuco R , Hexsel D. Gummy smile and botulinum toxin : a newapproach based on the gingival exposure area. J Am Acad Dermatol,2010, 63 (6) : 1042-1051.
  • 7Xiao Z, Zhang F , Lin W , Zhang M, Liu Y. Effect of botulinumtoxin type A on transforming growth factor betal in fibroblasts derivedfrom hypertrophic scar : a preliminary report. Aesthetic PlastSurg, 2010, 34 (4) : 424427.
  • 8Wang J , Hori K , Ding J , Huang Y, Kwan P , Ladak A , TredgetEE. Toll-like receptors expressed by dermal fibroblasts contributeto hypertrophic scarring. J Cell Physiol, 2011, 226 (5) : 12651273.
  • 9Xiao Z, Zhang M, Liu Y , Ren L. Botulinum toxin type a inhibitsconnective tissue growth factor expression in fibroblasts derivedfrom hypertrophic scar. Aesthetic Plast Surg, 2011, 35 (5 ):802-807.
  • 10Sidgwick GP, Bayat A. Extracellular matrix molecules implicatedin hypertrophic and keloid scarring. J Eur Acad Dermatol Venereol,2012, 26 (2) : 141-152.

引证文献7

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部